Condition: Severe Depression · Moderate Depression · Ketamine · Sponsor: Theresa Jacob, PhD, MPH
This is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.
This description comes directly from the study's public registry record.
Jessica Poster, MD · 718-283-8170 · JPoster@maimo.org
Always discuss trial participation with your own doctor first.
| Maimonides Medical Center | Brooklyn, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06752759